Uncategorized

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Dec 15, 2025: Finishing 10x Pluvicto; and, following up post-surgery for BRCA germline Gent

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Dec 9, 2025: Lotsa confusion throughout this week! To pick just one, Signatera MRD test.

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Mon. Dec 1, 2025: how do you pick a doctor for a second opinion?

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 25, 2025: Robust discussion around testoterone early – and thoughts about combining therapies at the end.

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 17, 2025: Assessing recurrence and IDC-P repeat this week

Hi-Risk/Recurrent/Advanced PrCa Video Chat: Can abiraterone impact your hearing?

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 3, 2025: High volume de novo metastatic diagnosis calls for triplet therapy.

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct 20, 2025: Unpredictable & outstanding response to surgery for G4+5 man

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct 20, 2025: One Gent rechallenges Pluvicto… another follows rechallenge with a ‘triplet’

Hi-Risk/Recurrent/Advanced PrCa Video Chat 10/14/25: Bust your blinded trial by testing your own testosterone.

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Oct 6, 2025: What’s the right group for me?

Interpreting Prostate Needle Biopsies in Today’s World – Jonathan Epstein (Recording): Reliable biopsies are critical to selecting the right treatment at all stages of prostate cancer. Get it wrong and you may get too much or too little treatment.